Barclays’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-38,001
Closed -$357K 3796
2020
Q3
$357K Buy
38,001
+7,865
+26% +$73.9K ﹤0.01% 2472
2020
Q2
$230K Buy
30,136
+396
+1% +$3.02K ﹤0.01% 2737
2020
Q1
$185K Sell
29,740
-63,278
-68% -$394K ﹤0.01% 2581
2019
Q4
$1.13M Sell
93,018
-985
-1% -$12K ﹤0.01% 2220
2019
Q3
$1.09M Sell
94,003
-108,236
-54% -$1.25M ﹤0.01% 2208
2019
Q2
$2.02M Buy
202,239
+155,104
+329% +$1.55M ﹤0.01% 1800
2019
Q1
$607K Sell
47,135
-9,057
-16% -$117K ﹤0.01% 2491
2018
Q4
$854K Buy
56,192
+1,133
+2% +$17.2K ﹤0.01% 1920
2018
Q3
$1.1M Buy
55,059
+18,185
+49% +$364K ﹤0.01% 2195
2018
Q2
$720K Buy
36,874
+8,158
+28% +$159K ﹤0.01% 2053
2018
Q1
$578K Buy
28,716
+904
+3% +$18.2K ﹤0.01% 2196
2017
Q4
$369K Buy
27,812
+22,280
+403% +$296K ﹤0.01% 2290
2017
Q3
$103K Sell
5,532
-5,031
-48% -$93.7K ﹤0.01% 2696
2017
Q2
$194K Sell
10,563
-7,397
-41% -$136K ﹤0.01% 2451
2017
Q1
$404K Sell
17,960
-6,989
-28% -$157K ﹤0.01% 2084
2016
Q4
$869K Buy
24,949
+16,243
+187% +$566K ﹤0.01% 1567
2016
Q3
$213K Buy
8,706
+2,447
+39% +$59.9K ﹤0.01% 2110
2016
Q2
$150K Sell
6,259
-29,420
-82% -$705K ﹤0.01% 2214
2016
Q1
$820K Buy
35,679
+34,176
+2,274% +$785K ﹤0.01% 1492
2015
Q4
$45K Buy
1,503
+897
+148% +$26.9K ﹤0.01% 2529
2015
Q3
$23K Sell
606
-4,527
-88% -$172K ﹤0.01% 2810
2015
Q2
$353K Buy
5,133
+2,131
+71% +$147K ﹤0.01% 1882
2015
Q1
$162K Sell
3,002
-6,129
-67% -$331K ﹤0.01% 2345
2014
Q4
$383K Sell
9,131
-76,349
-89% -$3.2M ﹤0.01% 2112
2014
Q3
$2.65M Sell
85,480
-35,354
-29% -$1.1M ﹤0.01% 1267
2014
Q2
$2.42M Buy
120,834
+37,928
+46% +$759K ﹤0.01% 1269
2014
Q1
$1.58M Buy
82,906
+75,642
+1,041% +$1.44M ﹤0.01% 1437
2013
Q4
$175K Sell
7,264
-2,677
-27% -$64.5K ﹤0.01% 2719
2013
Q3
$209K Buy
9,941
+1,889
+23% +$39.7K ﹤0.01% 2597
2013
Q2
$179K Buy
+8,052
New +$179K ﹤0.01% 2747